Just In
Latest News about CLSD
Recent news which mentions CLSD
12 Health Care Stocks Moving In Tuesday's After-Market Session
January 17, 2023
From Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
January 09, 2023
From Benzinga
AiViva Reports That Their Promising New Treatment For Wet AMD Is Soon To Be Ready For Clinical Trials
November 14, 2022
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 10, 2022
November 10, 2022
From Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
November 02, 2022
From Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
October 27, 2022
From Benzinga
Biotech Daily: Regulatory Setback For CorMedix, Mersana & GSK In Cancer Pact, BARDA Funding For Opioid Overdose Hopeful
August 09, 2022
From Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
August 08, 2022
From Benzinga
From Benzinga
From Benzinga
From InvestorPlace
20 Stocks Moving in Wednesday's Pre-Market Session
April 27, 2022
From Benzinga
30 Stocks Moving in Tuesday's Pre-Market Session
March 22, 2022
From Benzinga
68 Biggest Movers From Yesterday
March 16, 2022
From Benzinga
38 Stocks Moving In Tuesday's Mid-Day Session
March 15, 2022
From Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
March 14, 2022
From Benzinga
95 Biggest Movers From Friday
March 14, 2022
From Benzinga
From Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
March 11, 2022
From Benzinga
From Benzinga
50 Stocks Moving In Friday's Mid-Day Session
March 11, 2022
From Benzinga
From Benzinga
From InvestorPlace
30 Stocks Moving in Friday's Pre-Market Session
March 11, 2022
From Benzinga
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.